Roche Holding AG (RHHBF)
OTCMKTS · Delayed Price · Currency is USD
335.90
0.00 (0.00%)
Nov 5, 2025, 4:00 PM EST
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
$773,189
Profits / Employee
$114,831
Market Cap
281.75B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Chrome Holding Co. | 265 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
Roche Holding AG News
- 3 days ago - Genentech to Present New Data From Its Broad and Innovative Hematology Portfolio at ASH 2025 - Business Wire
- 3 days ago - Roche to present new data from its broad and innovative haematology portfolio at ASH 2025 - GlobeNewsWire
- 3 days ago - Manifold Bio Announces Strategic Collaboration with Roche to Develop Multiple Next-Generation Brain Shuttles for Neurological Diseases - Business Wire
- 3 days ago - Positive Phase III Data for Genentech's Gazyva Show Significant Reduction in Disease Activity for Systemic Lupus Erythematosus - Benzinga
- 3 days ago - Positive phase III data for Roche's Gazyva/Gazyvaro show significant reduction in disease activity for systemic lupus erythematosus - GlobeNewsWire
- 3 days ago - Positive Phase III Data for Genentech's Gazyva Show Significant Reduction in Disease Activity for Systemic Lupus Erythematosus - Business Wire
- 6 days ago - ALNY Q3 Earnings and Revenues Top Estimates on Higher Amvuttra Sales - Nasdaq
- 7 days ago - Roche purchases shares in tender offer for 89bio, Inc - GlobeNewsWire